Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.
AuteursLaakmann E, Schmidt M, Lübbe K, Agostinetto E, van Ramshorst M, Decker T, Malter W, Schettini F, Sousa MF, Denkert C, Neunhöffer T, Matos L, Linn S, Thill M, Weide R, Fitzpatrick A, Batista MV, Mundhenke C, Park-Simon TW, Le Du F, Riecke K, Fehm T, Witzel I, Rey J, Nekljudova V, Loibl S, Müller V
Cutaneous Hemangioma With Epithelioid Features Harboring TPM3/4::ALK Fusions: A Distinct Entity or a Molecular Variant of Epithelioid Hemangioma?
AuteursDehner CA, Jour G, Gassenmaier M, Michal M, de Saint Aubain N, Papke DJ, Umphress B, Li A, Tanner MM, Calonje E, Brenn T, Fletcher CDM, Mentzel T, Busam K, Linos K
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals.
AuteursLehmann J, Dragan T, Rammant E, de Ligt KM, Lai-Kwon J, Lidington E, Bultijnck R, Dejaco D, Taylor KJ, Gašpert T, Colombo E, Madariaga A, Brandão M, Nicolay JP, Zerdes I, Bosisio F, Correia D, Pellerino A, Marquina G, Fontes-Sousa M, Grisay G, Silva T, Siebenhüner A, Cammarota A, Szturz P
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
AuteursZerdes I, Matikas A, Mezheyeuski A, Manikis G, Acs B, Johansson H, Boyaci C, Boman C, Poncet C, Ignatiadis M, Bai Y, Rimm DL, Cameron D, Bonnefoi H, Bergh J, MacGrogan G, Foukakis T
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer.
AuteursVolders PJ, Aftimos P, Dedeurwaerdere F, Martens G, Canon JL, Beniuga G, Froyen G, Van Huysse J, De Pauw R, Prenen H, Lambin S, Decoster L, Vaeyens F, Rottey S, Van Dam PJ, Decoster L, Rutten A, Schreuer M, Loontiens S, Van der Meulen J, Mebis J, Cuppens K, Tejpar S, Vanden Bempt I, De Grève J, Schröder D, van Marcke C, Van Den Bulcke M, de Azambuja E, Punie K, Maes B
Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.
AuteursCaluwé A, Bellal S, Cao K, Peignaux K, Remouchamps V, Baten A, Longton E, Bessieres I, Vu-Bezin J, Kirova Y, Gestel DV, Desmoulins I, Ignatiadis M, Romano E, Buisseret L, Piccart M, Vandekerkhove C, Gulyban A, Poortmans P
